Wednesday, March 05, 2025 | 04:29 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

2 billion Covid-19 doses a long haul, but most will be covered by December

SII aims to make 50 million doses of Covovax (the Novavax vaccine) per month at its Pune plant

Medics inoculate doses of COVID-19 vaccine to people during the third phase of the vaccination drive, at BKC Jumbo Covid Centre in Mumbai on Saturday. COVID-19 vaccination drive for people above 18 years has begun.
Premium

In the July quarter, SII will scale up this capacity to make 100 million doses a month of Covishield.

Sohini Das Mumbai
While two billion doses of Covid-19 vaccines by the end of this year may be difficult, industry and analysts say a significant portion of the adult population can be covered with at least one dose by December.
 
The ambitious ramp-up plans, however, depend on the availability of raw material, the ability to scale up manufacturing drug substances, and forging partnerships to use the “fill-and-finish” capacities to their fullest.
 
The world’s largest vaccine maker by volumes — Serum Institute of India (SII) — is making 70 million doses a month of Covishield and has started stockpiling Novavax vaccines too.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in